189 related articles for article (PubMed ID: 28284028)
1. Modulation of oncogenic signaling networks by Kaposi's sarcoma-associated herpesvirus.
Wong JP; Damania B
Biol Chem; 2017 Jul; 398(8):911-918. PubMed ID: 28284028
[TBL] [Abstract][Full Text] [Related]
2. Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1.
Qin D; Feng N; Fan W; Ma X; Yan Q; Lv Z; Zeng Y; Zhu J; Lu C
BMC Microbiol; 2011 Oct; 11():240. PubMed ID: 22032493
[TBL] [Abstract][Full Text] [Related]
3. 3D culture conditions support Kaposi's sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells.
Dubich T; Dittrich A; Bousset K; Geffers R; Büsche G; Köster M; Hauser H; Schulz TF; Wirth D
J Mol Med (Berl); 2021 Mar; 99(3):425-438. PubMed ID: 33484281
[TBL] [Abstract][Full Text] [Related]
4. KSHV: pathways to tumorigenesis and persistent infection.
Giffin L; Damania B
Adv Virus Res; 2014; 88():111-59. PubMed ID: 24373311
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration.
Giffin L; West JA; Damania B
mBio; 2015 Dec; 6(6):e01499-15. PubMed ID: 26646010
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
[TBL] [Abstract][Full Text] [Related]
7. Signal Transduction Pathways Associated with KSHV-Related Tumors.
Watanabe T; Sugimoto A; Hosokawa K; Fujimuro M
Adv Exp Med Biol; 2018; 1045():321-355. PubMed ID: 29896674
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
Viejo-Borbolla A; Schulz TF
AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cell signaling pathways by Kaposi's sarcoma-associated herpesvirus (KSHVHHV-8).
Damania B
Cell Biochem Biophys; 2004; 40(3):305-22. PubMed ID: 15211030
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-κB signaling pathways.
Zhu X; Zhou F; Qin D; Zeng Y; Lv Z; Yao S; Lu C
J Mol Biol; 2011 Jul; 410(5):1035-51. PubMed ID: 21763505
[TBL] [Abstract][Full Text] [Related]
11. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
Kalt I; Masa SR; Sarid R
Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
[TBL] [Abstract][Full Text] [Related]
12. Modulation of Kaposi's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection.
Pan H; Xie J; Ye F; Gao SJ
J Virol; 2006 Jun; 80(11):5371-82. PubMed ID: 16699017
[TBL] [Abstract][Full Text] [Related]
13. Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes.
Direkze S; Laman H
Int J Exp Pathol; 2004 Dec; 85(6):305-19. PubMed ID: 15566428
[TBL] [Abstract][Full Text] [Related]
14. A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.
Li W; Jia X; Shen C; Zhang M; Xu J; Shang Y; Zhu K; Hu M; Yan Q; Qin D; Lee MS; Zhu J; Lu H; Krueger BJ; Renne R; Gao SJ; Lu C
Oncotarget; 2016 May; 7(22):32286-305. PubMed ID: 27058419
[TBL] [Abstract][Full Text] [Related]
15. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells.
Wang L; Damania B
Cancer Res; 2008 Jun; 68(12):4640-8. PubMed ID: 18559509
[TBL] [Abstract][Full Text] [Related]
17. Role of Interleukin-1 Family Members and Signaling Pathways in KSHV Pathogenesis.
Barrett L; Chen J; Dai L; Plaisance-Bonstaff K; Del Valle L; Qin Z
Front Cell Infect Microbiol; 2020; 10():587929. PubMed ID: 33194830
[TBL] [Abstract][Full Text] [Related]
18. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
19. Raf/MEK/ERK signalling triggers reactivation of Kaposi's sarcoma-associated herpesvirus latency.
Ford PW; Bryan BA; Dyson OF; Weidner DA; Chintalgattu V; Akula SM
J Gen Virol; 2006 May; 87(Pt 5):1139-1144. PubMed ID: 16603514
[TBL] [Abstract][Full Text] [Related]
20. [Kaposi's sarcoma-associated herpesvirus and mechanisms of oncogenesis].
Fujimuro M
Uirusu; 2006 Dec; 56(2):209-18. PubMed ID: 17446670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]